Our data in human breast cancer cell lines suggest that epigenetic silencing of CREB3L1 contributes to reducing CREB3L1 mRNA expression for at least some cell lines, an effect that was reversed by the inhibition of histone acetylation with TSA and/or inhibition of DNA methylation with DAC. Here, CREB3L1 is linked to breast carcinoma.